Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2020

View Archived Issues

A Tau-sand forms of tau?

FDA approves IND for SFA-002 study in psoriasis

GDF-15 proposed as a biomarker for coronary artery lesions in Kawasaki disease

miR-375 and miR-3687 are potential prognostic markers in enzalutamide-treated patients with mCRPC

SARS-CoV-2 Ab cocktails binding to distinct nonoverlapping regions of S protein prevent viral escape

Zanubrutinib demonstrates durable responses in patients with marginal zone lymphoma

RevImmune launches phase II U.K. study of CYT-107 for COVID-19

Preclinical studies show promise of GLP-1R agonist GL-0034 for treating diabetes

Japanese approval for Samsca for hyponatremia secondary to SIADH in adults

Shape-shifting DENV3 evades vaccines, therapeutics

Interim data reported from phase I study of INO-4800 vaccine for COVID-19

Antag Therapeutics describes new gastric inhibitory polypeptide receptor antagonists

Topline data from pivotal CONNECT-FX study of Zygel in fragile X syndrome

Dosing completed in first dose-escalation cohorts of phase I/II study of RTX-240

New galectin-3 inhibitors discovered at Bristol-Myers Squibb

Novartis patents chondrogenesis inducers

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group disclose S1P1 agonists

New PI3K inhibitors identified at Innovent Biologics

Researchers present preclinical data on EDIT-301 for sickle cell disease

Exelixis initiates phase III CONTACT-02 study of cabozantinib plus atezolizumab in CRPC

Ilumya approved in Japan for plaque psoriasis

Hoth enters sponsored research agreement with VCU for potential peptide COVID-19 therapeutic

Bavencio approved in U.S. as first-line maintenance in urothelial carcinoma

Innovent Biologics' bispecific antibody IBI-323 blocks PD-L1 and LAG-3

Amniox begins first phase III trial of TTAX-01 in diabetic foot ulcers

Lysogene collaborates with Weizmann Institute of Science on gene therapy for Gaucher and Parkinson's

FDA approves Dojolvi for long-chain fatty acid oxidation disorders

Corcept opens phase III study of relacorilant with nab-paclitaxel for metastatic pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...